ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy
Angiopoietin-like 4 (ANGPTL4) is an important regulator of plasma triglyceride (TG) levels and an attractive pharmacological target for lowering plasma lipids and reducing cardiovascular risk. Here, we aimed to study the efficacy and safety of silencing ANGPTL4 in the livers of mice using hepatocyte...
Main Authors: | Mingjuan Deng, Elda Kutrolli, Anne Sadewasser, Sven Michel, Masoumeh Motamedi Joibari, Frank Jaschinski, Gunilla Olivecrona, Stefan K. Nilsson, Sander Kersten |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227522000700 |
Similar Items
-
Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion1[S]
by: Yan Wang, et al.
Published: (2015-07-01) -
Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice[S]
by: Antwi-Boasiako Oteng, et al.
Published: (2019-10-01) -
ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure
by: Wieneke Dijk, et al.
Published: (2015-10-01) -
Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids[S]
by: Yan Q. Chen, et al.
Published: (2020-08-01) -
Characterization of sexual dimorphism in ANGPTL4 levels and function
by: Mingjuan Deng, et al.
Published: (2024-04-01)